abstract |
(57) [Summary] [Structure] The present invention relates to an improved method for producing an oligosaccharide-conjugated vaccine. In another aspect of the invention, Oligosaccharide vaccines are produced that induce monospecific and homogeneous immunity in response to capsular polysaccharide. [Effects] A specific embodiment of the present invention provides a vaccine that induces immunity to common serotypes of S. pneumoniae. |